Golpe, Rafael https://orcid.org/0000-0002-3759-5322
Article History
Received: 4 November 2025
Accepted: 2 January 2026
First Online: 27 January 2026
Declarations
:
: Rafael Golpe has received fees for lectures and funding for conference attendance from AstraZeneca, GSK, Novartis, FAES, Chiesi, Mundipharma, Menarini, TEVA, Grifols, Ferrer, Boehringer Ingel-heim, Rovi, and Gebro.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.